[1] 侯清涛,李芸,李舍予,等.全球糖尿病疾病负担现状[J].中国糖尿病杂志,2016,24(1):92
HOU QT,LI Y,LI SY,et al.The global burden of diabetes mellitus[J].Chin J Diabetes,2016,24(1):92
[2] 王学光. 二甲双胍联合阿卡波糖治疗2型糖尿病临床疗效分析[J].糖尿病新世界,2022,25(11):102
WANG XG.Clinical analysis of metformin combined with acarbose in the treatment of type 2 diabetes[J].Diabetes New World,2022,25(11):102
[3] LAVERY LA,SULUDERE MA,RYAN E,et al.The infected diabetic foot:analysis of diabetic and non-diabetic foot infections[J].Wound Repair Regen,2024,32(4):360
[4] 范梦迪,李俊,付威,等.SGLT-2抑制剂治疗2型糖尿病合并非酒精性脂肪肝[J].西部医学,2021,33(10):1496
FAN MD,LI J,FU W,et al.Curative effect of SGLT-2 inhibitors on type 2 diabetes mellitus combined with nonalcoholic fatty liver disease[J].Med J West China,2021,33(10):1496
[5] WANG Q,CHENG HM,JIANG SS,et al.The relationship between diabetic retinopathy and diabetic nephropathy in type 2 diabetes[J].Front Endocrinol,2024,15:1292412
[6] PEDERSEN FN,STOKHOLM L,ANDERSEN N,et al.Risk of diabetic retinopathy according to subtype of type 2 diabetes[J].Diabetes,2024,73(6):977
[7] 尹华静,余珊珊,尹茂山,等.重组人胰岛素类似物研发进展和安全性特点[J].中国新药杂志,2018,27(21):2578
YIN HJ,YU SS,YIN MS,et al.Research progress and safety characteristics of recombinant human insulin analogues[J].Chin J New Drugs,2018,27(21):2578
[8] 朱大龙,张红.谷赖胰岛素:一种新型速效人胰岛素类似物[J].药品评价,2012,9(22):47
ZHU DL,ZHANG H.Insulin glulisine:a new rapid-acting insulin analogue[J].Drug Eval,2012,9(22):47
[9] 钱建钦,何佳佳,朱坤丹,等.多种质谱解离技术对缩宫素结构表征的比较研究[J].中国现代应用药学,2023,40(6):803
QIAN JQ,HE JJ,ZHU KD,et al.Characterization of oxytocin by different kinds of dissociation methods using high resolution mass spectrometry:a comparative study[J].Chin J Mod Appl Pharm,2023,40(6):803
[10] 杜加亮,于传飞,王文波,等.重组抗IL-36受体单克隆抗体药物的质量控制研究[J].山西医科大学学报,2022,53(10):1331
DU JL,YU CF,WANG WB,et al.Study on quality control of recombinant anti-IL-36 receptor monoclonal antibody[J].J Shanxi Med Univ,2022,53(10):1331
[11] 周勇,王丽,于传飞,等.PEG化重组人促红素质量控制方法和标准研究[J].药物分析杂志,2012,32(4):661
ZHOU Y,WANG L,YU CF,et al.Study on methods and requirements for quality control of Pegylated Erythropoietin(PEG-EPO)[J].Chin J Pharm Anal,2012,32(4):661
[12] 付志浩,武刚,李萌,等.重组抗白细胞介素23单克隆抗体的质量研究[J].中国新药杂志,2021,30(19):1738
FU ZH,WU G,LI M,et al.Quality study of recombinant anti-interleukin-23 monoclonal antibodies[J].Chin J New Drugs,2021,30(19):1738
[13] 吴宏斌,邱文娜,李磊,等.重组艾塞那肽RP-HPLC法肽图分析[J].中国医药科学,2016,6(7):59
WU HB,QIU WN,LI L,et al.Peptide mapping analysis of recombinant Exendin-4 by RP-HPLC[J].Chin Med Pharm,2016,6(7):59
[14] 周艳卿,蒋小岗.Edman降解中异硫氰酸苯酯新修饰位点的发现和验证[J].色谱,2016,34(8):752
ZHOU YQ,JIANG XG.Discovery and validation of a novel modification by phenyl isothiocyanate in Edman degradation[J].Chin J Chromatogr,2016,34(8):752
[15] 田沛霖,张国林.重组人胰岛素原料药N末端氨基酸序列的测定[J].中国合理用药探索,2020,17(12):89
TIAN PL,ZHANG GL.Determination of the N-terminal amino acid sequence in the API of recombinant human insulin[J].Chin J Rational Drug Use,2020,17(12):89
[16] 郭玮,于传飞,李萌,等.N端测序作为单克隆抗体常规放行分析方法的探讨[J].生物工程学报,2014,30(9):1473
GUO W,YU CF,LI M,et al.N terminal sequencing for practical detection of monoclonal antibody[J].Chin J Biotechnol,2014,30(9):1473
[17] RÉVÉSZ Á,ROKOB TA,JEANNE DFD,et al.Optimal collision energies and bioinformatics tools for efficient bottom-up sequence validation of monoclonal antibodies[J].Anal Chem,2019,91(20):13128
[18] KURIL AK,SARAVANAN K.High-throughput method for peptide mapping and amino acid sequencing for calcitonin salmon in calcitonin salmon injection using ultra high performance liquid chromatography-high resolution mass spectrometry(UHPLC-HRMS)with the application of Bioinformatic tools[J].J Pharm Biomed Anal,2024,243:116093
[19] BABOVIĆ M,SHLIAHA PV,GIBB S,et al.Effective amino acid sequencing of intact filgrastim by multimodal mass spectrometry with topdownr[J].J Am Soc Mass Spectrom,2022,33(11):2087
[20] LEVY MJ,GUCINSKI AC,BOYNE MT.Primary Sequence confirmation of a protein therapeutic using top down MS/MS and MS(3)[J].Anal Chem,2015,87(14):6995
[21] 胡馨月,丁晓丽,孙悦,等.利用LC-MS/MS法解析化学修饰型胰岛素类似物的氨基酸序列[J].中国新药杂志,2023,32(3):301
HU XY,DING XL,SUN Y,et al.Identification of amino acid sequence of chemically modified insulin analogues by LC-MS/MS[J].Chin J New Drugs,2023,32(3):301
